CannTrust Holdings Inc. Stock Other OTC
Equities
CNTTQ
CA1378002077
Pharmaceuticals
Financials (USD)
Sales 2017 | 20.7 | Sales 2018 | 45.65 | Capitalization | 508M |
---|---|---|---|---|---|
Net income 2017 | 6M | Net income 2018 | -13M | EV / Sales 2017 | 31,215,427 x |
Net cash position 2017 | 17.16M | Net cash position 2018 | 58M | EV / Sales 2018 | 9,864,003 x |
P/E ratio 2017 |
81.5
x | P/E ratio 2018 |
-34.5
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-18 |
David Blair
DFI | Director of Finance/CFO | - | 19-09-30 |
Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Greg Guyatt
CEO | Chief Executive Officer | - | 19-02-18 |
Dan Hogan
BRD | Director/Board Member | - | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.01B | |
-18.38% | 4.4B | |
-9.17% | 3.17B | |
+3.98% | 3.07B | |
-3.41% | 2.51B | |
+48.74% | 1.88B | |
-4.82% | 1.73B | |
-1.24% | 1.65B | |
-8.96% | 1.58B |